About this journal
Aims and scope
Medical Devices: Evidence and Research is an international, peer-reviewed, open access journal that focuses on evidence, technology, research, and expert opinion supporting use and application of medical devices. This informs advances in diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.
Focus areas of the journal
This journal ultimately provides an evidence-based resource for the development and use of medical devices, covering specific areas such as:
• Surgery and anesthesia
• Instrumentation (diagnostics and analytics)
• Active and non-active implantable technology
• Dental and ophthalmic applications
• Drug delivery
Key features of the journal are the identification of novel devices and optimal use of existing devices, which lead to improved clinical outcomes and more effective patient management and safety.
Acceptable study types
All meta-analyses require a pre-submission check prior to submitting to Medical Devices: Evidence and Research. Please complete the pre-submission check form here.
Acceptable article types
The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas and clinical situations. Particularly welcome are papers outlining ideas and techniques related to medical devices.
Journal metrics
Usage
- 76K annual downloads/views
Citation metrics
- 1.3 (2023) Impact Factor
- 1.7 (2023) 5 year IF
- 2.8 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.531 (2023) SNIP
- 0.372 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editors-in-Chief:
Professor Steve Campbell, Clinical Redesign, Nursing, School of Health Sciences, University of Tasmania, Australia
Dr Scott Fraser, Consultant Ophthalmologist, Sunderland Eye Infirmary, United Kingdom
Editorial Board:
Dr Seza Apiliogullari, Associate Professor, Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA, United States
Professor Irving Bigio, Department of Biomedical Engineering, Boston University, Boston, United States
Dr Giuseppe Biondi-Zoccai, Department Of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Latina, Italy
Professor Lawton R. Burns, Health Care Management, University of Pennsylvania, Philadelphia, PA, United States
Dr Laura Cercenelli, Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy
Dr Fabrizio Cutolo, Department of Information Engineering, University of Pisa, Italy
Professor Adel Denewer, Mansoura Oncology Center and head of surgical departments , Mansoura Universty, Egypt
Professor Robert Denniss, School of Medicine, University of Western Sydney, Australia
Professor Dominique Durand, Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States
Professor William Federspiel, Department of Bioengineering, Critical Care Medicine and Chemical Engineering, University of Pittsburgh, PA, United States
Professor Amit Gefen, Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel
Dr Boris Gramatikov, Laboratory of Ophthalmic Optics, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States
Professor Paul Hansma, Neuroscience Research Institute, Faculty in California NanoSystems Institute, Emeritus Professor in Dept. of Physics, University of California, Santa Barbara, CA, United States, Co-founder of Active Life Scientific, Inc
Dr Alexander Kalashnikov, Engineering and Maths, Sheffield Hallam University, United Kingdom
Prof. Dr. Mutlu Özcan, Dental Materials Unit, University of Zurich, Switzerland
Ms Falguni Parikh, Clinical Scientist in Merck, United States
Prof. Dr. Gürel Pekkan, Faculty of Dentistry, Department of Prosthodontics, University of Turin, Turkey
Professor Guy Salama, Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, PA, United States
Dr Mark Schweitzer, Dr, Vice President of Health Affairs, Wayne State University, MI, United States
Professor K. Kirk Shung, Biomedical Engineering at University of Southern California, Retired, United States
Dr Tom van der Touw, School of Science & Technology, Discipline of Biomedical Sciences, University of New England, Armidale, NSW, Australia
Dr David Vilkomerson, DVX, Inc., Princeton, NJ, United States
Professor Stefan Weber, Center for Biomedical Engineering Research, University of Bern, Switzerland
Professor Thomas J Webster, Professor, Division of Pre-college and Undergraduate Studies, Brown University (United States); School of Health Sciences and Biomedical Engineering, Hebei University of Technology (China); and School of Engineering, Saveetha University (India).
Abstracting and indexing
Medical Devices: Evidence and Research is indexed/tracked/covered by the following services:
Compendex
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
Medical Devices: Evidence and Research is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
Continuous
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors